Literature DB >> 11991605

Anti-ENA antibodies in patients with chronic hepatitis C virus infection.

E D'Amico1, C Palazzi, P Cacciatore, A Canelli, G Ursitti, L Cosentino, V Dogali, G Riario-Sforza, F Capani.   

Abstract

The aim of the study was to assess the prevalence of anti-extractable nuclear antigen (ENA) antibodies in patients with chronic HCV infection. We studied 69 consecutive patients with chronic hepatitis C, 59 control subjects with non-HCV liver diseases, and 22 control subjects with extrahepatic, non-immune-mediated, chronic diseases. Thirty-two (46.3%) of 69 patients with HCV infection had anti-ENA antibodies: 16 (23.1%) showed anti-SSA antibodies and 14 (20.2%) had anti-SSB antibodies. Four of the patients with HCV infection suffered from sicca syndrome and three of them had also anti ENA antibodies. The prevalence of anti-ENA antibodies was significantly higher in the anti-HCV subjects compared with both control groups. Twenty-six of 44 HCV-antibodies-positive females had anti-ENA antibodies, compared with 6 of 25 males, showing a sex related difference. In conclusion, our results outline a specific role of HCV infection in the induction of anti-ENA antibodies. Female sex seems a predisposing condition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991605     DOI: 10.1023/a:1014731731363

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients.

Authors:  H Verbaan; J Carlson; S Eriksson; A Larsson; R Liedholm; R Manthorpe; H Tabery; A Widell; S Lindgren
Journal:  J Intern Med       Date:  1999-02       Impact factor: 8.989

2.  Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients.

Authors:  M García-Carrasco; M Ramos; R Cervera; J Font; J Vidal; F J Muñoz; C Miret; G Espinosa; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1997-03       Impact factor: 19.103

3.  No evidence of HCV infection or liver disease in British patients with oral lichen planus.

Authors:  M Ingafou; S R Porter; C Scully; C G Teo
Journal:  Int J Oral Maxillofac Surg       Date:  1998-02       Impact factor: 2.789

4.  Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; J Coll; R Gerli; P Y Hatron; L Kater; Y T Konttinen; R Manthorpe; O Meyer; M Mosca; P Ostuni; R A Pellerito; Y Pennec; S R Porter; A Richards; B Sauvezie; M Schiødt; M Sciuto; Y Shoenfeld; F N Skopouli; J S Smolen; F Soromenho; M Tishler; M J Wattiaux
Journal:  Ann Rheum Dis       Date:  1996-02       Impact factor: 19.103

5.  Sicca syndrome associated with hepatitis C virus infection.

Authors:  C Jorgensen; M C Legouffe; P Perney; J Coste; B Tissot; C Segarra; C Bologna; L Bourrat; B Combe; F Blanc; J Sany
Journal:  Arthritis Rheum       Date:  1996-07

6.  Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome.

Authors:  C A Scott; C Avellini; L Desinan; M Pirisi; G F Ferraccioli; P Bardus; C Fabris; L Casatta; E Bartoli; C A Beltrami
Journal:  Histopathology       Date:  1997-01       Impact factor: 5.087

7.  Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease.

Authors:  P Kurki; M Gripenberg; A M Teppo; M Salaspuro
Journal:  Liver       Date:  1984-04

8.  Nuclear antigens recognized by antibodies present in liver disease sera.

Authors:  E Penner; I Kindas-Mügge; E Hitchman; G Sauermann
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

9.  Significance of extractable nuclear antigens in childhood autoimmune liver disease.

Authors:  G V Gregorio; E T Davies; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.

Authors:  M Lenzi; S Bellentani; G Saccoccio; P Muratori; F Masutti; L Muratori; F Cassani; F B Bianchi; C Tiribelli
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

View more
  5 in total

Review 1.  Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Authors:  Merav Lidar; Noga Lipschitz; Nancy Agmon-Levin; Pnina Langevitz; Ori Barzilai; Maya Ram; Bat-Sheba Porat-Katz; Nicola Bizzaro; Jan Damoiseaux; Jan Willem Cohen Tervaert; Salvatore deVita; Stefano Bombardieri; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

2.  Is identification of anti-SSA and/or -SSB antibodies necessary in serum samples referred for antinuclear antibodies testing?

Authors:  Zaixing Yang; Yan Liang; Renqian Zhong
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

3.  Anti-ENA antibody profiles in patients with hepatitis C virus infection.

Authors:  Christine M Litwin; Angela R Rourk
Journal:  J Clin Lab Anal       Date:  2017-06-12       Impact factor: 2.352

4.  Anti-SSB/La antibody is negatively associated with HLA-DR2 in chronic hepatitis C infection.

Authors:  Chien-Sheng Wu; Chung-Yi Hu; Ping-Ning Hsu
Journal:  Clin Rheumatol       Date:  2007-11-09       Impact factor: 2.980

Review 5.  Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.

Authors:  Carlo Palazzi; Emilio D'Amico; Salvatore D'Angelo; Michele Gilio; Ignazio Olivieri
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.